88207 20200716101441.0 doi 10.1016/j.drudis.2019.03.014 sideral 111250 ART-2019-111250 eng (orcid)0000-0002-8585-6371 Bayona-Bafaluy, M.P. Universidad de Zaragoza Oxidative phosphorylation inducers fight pathological angiogenesis 2019 Access copy available to the general public Unrestricted Pathological mutations in subunits of the oxidative phosphorylation (OXPHOS) system, or inhibitors of this biochemical pathway, increase the production of vascular endothelial growth factor (VEGF) and pathological angiogenesis. In many angiogenesis-related diseases, such as retinal, rheumatoid diseases, or cancer, OXPHOS dysfunction can be found. Thus, enhancing OXPHOS might be a promising therapeutic approach for pathologic angiogenesis. info:eu-repo/grantAgreement/ES/DGA/B33-17R info:eu-repo/grantAgreement/ES/DGA/FEDER info:eu-repo/grantAgreement/ES/ISCIII/PI17-00021 info:eu-repo/grantAgreement/ES/ISCIII/PI17-00166 info:eu-repo/semantics/openAccess by-nc-nd http://creativecommons.org/licenses/by-nc-nd/3.0/es/ 7.321 2019 1.896 2019 PHARMACOLOGY & PHARMACY 12 / 270 = 0.044 2019 Q1 T1 Pharmacology 2019 Q1 Drug Discovery 2019 Q1 info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion Esteban, O. (orcid)0000-0001-9876-5850 Ascaso, J. Universidad de Zaragoza (orcid)0000-0003-1770-6299 Montoya, J. Universidad de Zaragoza (orcid)0000-0002-0269-7337 Ruiz-Pesini, E. Universidad de Zaragoza 1004 646 Universidad de Zaragoza Dpto. Cirugía,Ginecol.Obstetr. Área Oftalmología 1002 060 Universidad de Zaragoza Dpto. Bioq.Biolog.Mol. Celular Área Bioquímica y Biolog.Mole. 19 (2019), 30035-2 Drug discov. today DRUG DISCOVERY TODAY 1359-6446 143377 http://zaguan.unizar.es/record/88207/files/texto_completo.pdf Postprint 46492 http://zaguan.unizar.es/record/88207/files/texto_completo.jpg?subformat=icon icon Postprint oai:zaguan.unizar.es:88207 articulos driver 2020-07-16-08:59:16 ARTICLE